321.20MMarket Cap21.81P/E (TTM)
5.949High5.740Low353.74KVolume5.850Open5.770Pre Close2.07MTurnover0.98%Turnover Ratio1.98P/E (Static)54.53MShares11.72052wk High0.96P/B213.52MFloat Cap5.71052wk Low--Dividend TTM36.25MShs Float31.910Historical High--Div YieldTTM3.62%Amplitude2.460Historical Low5.840Avg Price1Lot Size
Voyager Therapeutics Stock Forum
This was over $10 recently, and earnings were great, except Wall St was scared of recession at the time. I'm guessing once they are satisfied, this will go back up
Dow Jones· 2 mins ago
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
Voyager to receive upfront consideration of $15 million and is eligible to receive up to $305 million in potential associated milestone payments and royalties
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
Voyager Therapeutics (Nasdaq: VYGR) has announced a new license agreement with Novartis AG (NYSE: NVS) for a novel capsid from Voyager's TRACER™ capsid discovery platform. The capsid will be used in a gene therapy program targeting an undisclosed rare neurologic disease. This agreement expands Voyager's partnered portfolio of TRACER-enabl...
Looks like 6 holds the big buy but we shall see. Don't expect it to get much lower.
Voyager Therapeutics Says First Participants Dosed In Single Ascending Dose Trial of VY-TAU01 For Treatment Of Alzheimer's Disease
No comment yet